According to the National Organisation for Rare Disorders, warm autoimmune hemolytic anaemia (wAIHA) is the most common subtype of autoimmune hemolytic anaemia, affecting approximately 1 to 3 per 100,000 people every year.     Warm Autoimmune Hemolytic Anemia Drug Pipeline Analysis Th